SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CALYPTE BIOMEDICAL
(NQPK:CBMC Last Sale: .006 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (CBMC : $.006)
$4 million Market Cap at September 13, 2013
Employs 12.
Medical Products SubIndustry up .00% / Health Industry up .00% Today
5 Centerpointe Drive Research Report Earnings Snapshot - Last
Suite 400 Fact Sheet
Lake Oswego, OR 97035 Financial Statements
Phone: 971-204-0282 Peer Comparison
Annual Reports

Roger I. Gale, Chmn./CEO, Richard D. Brounstein, CFO.
Transfer to (OTCBB:CBMC). Focused on the development and commercialization of diagnostic testing products for the detection of sexually transmitted diseases. IPO at $6 July 25, 1996. Raised $13.8 MM, selling 2.3 MM shares, 23% of the outstanding. Lead Manager: Pacific Growth Equities.
Historical Charts    Technical Analysis
No Historical Data available for CBMC

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CBMC $.006 $ 0 $.0043 $.006 10,300 $.0013 $.01 700,168
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $4,201

A174
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex